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ocal adhesion kinase (FAK) is a critical mediator of
signal transduction by integrins and growth factor
receptors in a variety of cells including endothelial
cells (ECs). Here, we describe EC-speciﬁc knockout of
FAK using a Cre-loxP approach. In contrast to the total
FAK knockout, deletion of FAK speciﬁcally in ECs did not
affect early embryonic development including normal
vasculogenesis. However, in late embryogenesis, FAK de-
letion in the ECs led to defective angiogenesis in the em-
bryos, yolk sac, and placenta, impaired vasculature and
F
 
associated hemorrhage, edema, and developmental de-
lay, and late embryonic lethal phenotype. Histologically,
ECs and blood vessels in the mutant embryos present
a disorganized, detached, and apoptotic appearance.
Consistent with these phenotypes, deletion of FAK in ECs
isolated from the ﬂoxed FAK mice led to reduced tubulo-
genesis, cell survival, proliferation, and migration in
vitro. Together, these results strongly suggest a role of FAK
in angiogenesis and vascular development due to its es-
sential function in the regulation of multiple EC activities.
 
Introduction
 
Blood vessel formation is fundamental to embryonic develop-
ment and organogenesis, as well as to the pathogenesis of many
diseases including coronary heart disease, diabetes, retinopa-
thies, and cancer (Dvorak, 2003). Blood vessels are formed by
two processes: vasculogenesis, whereby a primitive vascular
network is established during embryogenesis from the pluripo-
tent mesenchymal progenitors, and angiogenesis, in which the
growth of new capillaries occurs from the preexisting vessels
(Yancopoulos et al., 1998). Endothelial cells (ECs) play a piv-
otal role in both vasculogenesis and angiogenesis, and function
as both transducers and effectors of local environmental signals
for vessel formation. Multiple cell surface receptors and their
ligands have been shown to play important roles in the regula-
tion of blood vessel formation. These include proangiogenic
growth factors and their receptors on EC, multiple integrins, and
their ECM ligands (Yancopoulos et al., 1998; Hynes, 2002).
However, much less is known about the roles and mechanisms
of the intracellular signaling pathways triggered by these recep-
tors in the regulation of angiogenesis and vasculogenesis.
FAK is a cytoplasmic tyrosine kinase that plays a key
role in integrin-mediated signal transduction pathways (Par-
sons, 2003; Schlaepfer and Mitra, 2004). Integrin-mediated
cell adhesion leads to FAK activation and autophosphoryla-
tion in a variety of cell types. Activated FAK associates with a
number of Src homology 2 domain–containing signaling mol-
ecules including Src family kinases, p85 subunit of PI3K,
phospholipase C-
 
 
 
, and Grb7 (Parsons, 2003). FAK binding to
Src family kinases contributes to the activation of both ki-
nases, which leads to phosphorylation of several other sites on
FAK and a number of other substrates including paxillin
(Burridge et al., 1992; Schaller and Parsons, 1995), p130cas
(Vuori et al., 1996; Ruest et al., 2001), and Shc (Schlaepfer et
al., 1998). FAK and its interactions with these signaling mole-
cules have been shown to trigger several downstream signal-
ing pathways that regulate cell spreading and migration, cell
survival, and cell cycle progression (Parsons, 2003; Schlaepfer
and Mitra, 2004).
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Consistent with its critical roles in vitro, FAK gene
knockout in mice resulted in an embryonic lethal phenotype
due to defects in the axial mesodermal tissues and cardiovascu-
lar system (Ilic et al., 1995). Both vasculogenesis and angio-
genesis of the vasculature were impaired and neither a normal
heart nor fully developed blood vessels were present in the
FAK-null embryos. These results suggested a crucial role of
FAK in the development of the vasculature. However, the rela-
tively early (E8.5) embryonic lethality prevented analysis of
the role of FAK in the late stage of embryonic development in-
cluding angiogenesis in vivo.
A potential role of FAK in angiogenesis has also been
suggested by a number of other studies. During the mouse em-
bryo development, FAK expression became increasingly re-
stricted to the blood vessels (Polte et al., 1994). Increased EC
migration into a wounded monolayer was correlated with in-
creased tyrosine phosphorylation and kinase activity of FAK
(Romer et al., 1994). In addition, activation of VEGF recep-
tor-2 by VEGF-A induced association of FAK with PI3-kinase,
which is required for the stimulation of migration of porcine
aortic ECs (Qi and Claesson-Welsh, 2001). Angiopoietin-1,
another angiogenesis stimulator, also increased FAK phos-
phorylation during angiogenesis in vitro (Kim et al., 2000a).
Lastly, several members of the integrin family play important
roles in the regulation of angiogenesis (Eliceiri and Cheresh,
2001). A recent report also showed that formation of a signal-
ing complex containing FAK and integrin 
 
 
 
v
 
 
 
5 in an Src-
dependent manner is essential for VEGF-stimulated angio-
genesis (Eliceiri et al., 2002). Given FAK’s role in mediating
signaling by integrins and growth factor receptors, these re-
sults also strongly suggest a potential role for FAK in vasculo-
genesis and angiogenesis.
To investigate the physiological role of FAK in vascular
development and angiogenesis in vivo, we generated a strain of
mice with FAK gene flanked by two loxP sites (floxed FAK).
Analysis of the EC-specific deletion of FAK embryos and iso-
lated ECs indicated a role for FAK in angiogenesis and vascular
development due to its essential function in the regulation of
multiple EC activities.
 
Results
 
Generation of floxed FAK mice
 
To enable ablation of the functional mouse 
 
FAK
 
 locus in a con-
ditional manner, we inserted two 
 
loxP
 
 sites flanking its third
coding exon followed by a neomycin resistance cassette and a
third 
 
loxP
 
 site via homologous recombination in embryonic
stem cells (Fig. 1 A). Cre-mediated deletion of exon 3 leads to a
frame-shift mutation because of directly splicing from exon 2
(containing the ATG initiation codon) to exon 4, which pro-
duces a small truncated and nonfunctional peptide (
 
 
 
70 aa)
lacking the majority of FAK sequences. Heterozygous mice
Figure 1. Generation of the floxed and total
deletion FAK allele. (A) Schematic of mouse
FAK protein, targeting vector, genomic and
the loxP modified FAK loci. Large filled trian-
gles represent loxP sites. The relevant restric-
tion sites (A, ApaI; S, SacI; and B, BamHI),
position of probe (thick line) for Southern blot-
ting, and primers (P1, P2, and P3) for PCR
genotyping are indicated. Crosses of the mice
with targeted allele with EII-a Cre mice result
in three possible outcomes at the FAK loci
(flox,   and neo ). (B and C) Southern blotting
analysis of the tail DNA from representative
mice after digests with ApaI (B) or SacI (C).
(D and E) Cell lysates were prepared from
lung (D) or embryos (E) of mice with various
genotypes as indicated. They were then ana-
lyzed by Western blotting using anti-FAK or
anti-vinculin, as indicated. 
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with the targeted allele (
 
FAK
 
flox-neo/
 
 
 
) were crossed with EIIa-
Cre mice to remove the neomycin resistance cassette that may
affect the normal expression of the targeted gene (hypomor-
phism) (Chen et al., 1993). This led to the generation of three
types offsprings with deletion of neomycin resistance cassette
(
 
FAK
 
flox/
 
 
 
), exon 3 deleted (
 
FAK
 
neo/
 
 
 
), or both (
 
FAK
 
 
 
/
 
 
 
). The
heterozygous floxed FAK (
 
FAK
 
flox/
 
 
 
) and FAK-null (
 
FAK
 
 
 
/
 
 
 
)
mice were identified by PCR analysis of tail DNA (unpublished
data) and confirmed by Southern blotting (Fig. 1, B and C). The
identified 
 
FAK
 
flox/
 
 
 
 mice were then bred with C57BL/6J mice to
segregate the floxed FAK allele from the EIIa-Cre transgene.
Matings between heterozygous 
 
FAK
 
flox/
 
 
 
 mice yielded
homozygous floxed FAK mice (
 
FAK
 
flox/flox
 
) at the expected
Mendelian ratio (unpublished data) that were viable, fertile,
and did not show gross or histological abnormalities. To ensure
normal expression of FAK gene flanked with 
 
loxP
 
 sequences,
FAK protein expressions in various mice strains were analyzed
by Western blotting. Fig. 1 D shows a similar expression level
of FAK in the lungs from 
 
FAK
 
flox/flox
 
 mice and wild-type mice
(
 
FAK
 
 
 
/
 
 
 
). As expected, both 
 
FAK
 
 
 
/
 
 
 
 and 
 
FAK
 
flox/
 
 
 
 mice
showed reduced expression of FAK, presumably due to the re-
moval of one FAK allele. Together, these results suggest that
the 
 
loxP
 
 sequences flanking the exon 3 of FAK did not affect
FAK expression or the normal development and function of
mice (thus not a hypomorphic allele).
Previous studies showed that deletion of the second kinase
exon resulted in FAK deficiency and early embryonic lethality
(Ilic et al., 1995). To test the effect of exon 3 deletion in FAK,
intercrosses of 
 
FAK
 
 
 
/
 
 
 
 heterozygous mice were performed.
Near-Mendelian ratios of wild-type, heterozygous, and ho-
mozygous embryos were detected at E7.5 and E8.5. A decrease
in the number of homozygous embryos was found at E9.5 and
E10.5, and no 
 
FAK
 
 
 
/
 
 
 
 
 
embryos were detected at or beyond
E11.5 (Table I and unpublished data). Analysis of lysates from
the E8.5 embryos confirmed the absence of FAK in the 
 
FAK
 
 
 
/
 
 
 
embryos (Fig. 1 E). These results are consistent with the previ-
ous studies that inactivation of 
 
FAK 
 
leads to embryonic lethal-
ity in early embryogenesis (Ilic et al., 1995) (also see Fig. 2 A,
d), although in our study the FAK gene is disrupted in a differ-
ent location. They also confirmed that deletion of exon 3 leads
to the loss of functional 
 
FAK
 
 locus in mice.
 
EC-specific FAK deletion in mice
 
To specifically inactivate the 
 
FAK
 
 gene in ECs, the floxed
FAK mice were intercrossed with transgenic mice expressing
Cre recombinase under the control of the Tie2 endothelial-spe-
cific promoter (Koni et al., 2001). Of the 161 viable offspring
of the crosses between 
 
FAK
 
 
 
/
 
 
 
; Tie2Cre males to 
 
FAK
 
flox/flox
 
 fe-
males analyzed, we obtained 52 
 
FAK
 
flox/
 
 
 
 progeny, 54 
 
FAK
 
flox/
 
 
 
;
Tie2Cre progeny, and 52 
 
FAK
 
flox/
 
 
 
 progeny, but only 5 
 
FAK
 
flox/
 
 
 
;
Tie2Cre (designated as conditional FAK knockout [CFKO])
progeny (Table II). Although the offsprings with three other
 
Table I. 
 
Genotypes of progeny from FAK
 
 
 
/
 
 
 
 heterozygous intercrosses
E7.5 E8.5 E9.5 E10.5 E11.5 Born
 
 
 
/
 
 
 
41 11 61 2 1 0 4 7
 
 
 
/
 
 
 
82 63 02 4 2 2 9 5
 
 
 
/
 
 
 
41 71 2 4 0 0
Total 16 54 58 40 32 143
Figure 2. EC-specific FAK deletion in mice. (A) E8.5 embryos with  / 
(a), flox/ ; Tie2Cre (CFKO) (b), flox/  (c), and  /  (d) genotypes. At
this stage, CFKO embryos (c) are indistinguishable from control embryos
(a and b), whereas FAK total KO embryos (d) showed a marked retarda-
tion in development and much reduced overall size. (B) Immunohistological
analysis for PECAM-1 and FAK on adjacent brain sections of control
and CFKO E9.5 embryos. Vascular ECs show positive staining with anti-
PECAM-1 in both control and CFKO embryos (arrows). FAK is detected in
the ECs of the control, but not CFKO, embryos (arrows). Neuroepithelium
(NE, bracketed) are stained with FAK in both control and CFKO embryos.
(C) Gross examination of whole embryos at E13.5 (a–d) or later (e and f),
with (b and d) or without (a, c, e, and f) intact amnion and implantation
sites. There are variable size hemorrhages (long arrows) in the CFKO em-
bryos. Note the lack of vascular network in the head and amnion of the
CFKO embryo when compared with the control littermates (red arrow-
heads). The amnion of CFKO embryos is thickened by edema (b and d, long
arrows). The later embryos (e and f) are two examples of the representative
range of abnormalities showing scattered hemorrhages and subcutaneous
edema (e, long arrow), and smaller embryo with marked discoloration due
to embryonic death and multifocal hemorrhages (f, long arrows). 
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genotypes are very close to the Mendelian ratio of this cross-
ing (25% each), the 3% pups with CFKO genotype is signifi-
cantly lower than the expected 25% of all pups, suggesting
potential embryonic lethal phenotype for the majority of
CFKO embryos.
To determine when these CFKO embryos die, embryos
were examined from E8.5 to birth (see Table II). Near-Mendelian
ratios of 1:1:1:1 were represented for the above four genotypes
including CFKO embryos between E8.5 and E12.5 (Table II).
CFKO embryos at E8.5 and E9.5 were indistinguishable from
the control littermates in morphology and development (Fig. 2
A). At E10.5, 
 
 
 
5% CFKO embryos showed developmental re-
tardation (unpublished data); however, the majority of embryos
at this stage and until E12.5 were seen normally in the overall
gross appearance and development (unpublished data). This is
in marked difference from the 
 
FAK
 
 
 
/
 
 
 
 
 
embryos that showed se-
vere developmental retardation as early at E8.5 (Fig. 2 A). By
E13.5, a decreased number of CFKO embryos (
 
 
 
15.6%) than
the expected 25% Mendelian ratio was found (Table II), and the
embryos exhibited various defects (see below). At E14.5 and
thereafter, a further deterioration and reduction in the number of
CFKO embryos was seen (Table II and unpublished data). EC-
specific FAK deletion was verified by immunohistological
analysis of the CFKO embryo and its control littermate at E9.5.
FAK expression was detected in ECs as marked by staining of
platelet-endothelial cell adhesion molecule-1 (PECAM-1) in the
control, but not CFKO embryos (Fig. 2 B). In contrast, FAK ex-
pression was detected in the neuroepithelium in both the control
and CFKO embryos, suggesting EC-specific inactivation of
FAK gene in CFKO embryos. Together, these results suggest
that EC-specific deletion of FAK leads to a late embryonic le-
thality in the majority of the embryos. They also suggest that
the total FAK KO mice likely have a broader deficiency than
the EC-specific CFKO, which is responsible for the early em-
bryonic lethal phenotype (Ilic et al., 1995).
 
Vascular defects in EC-specific CFKO 
embryos
 
Gross examination of CFKO embryos at E13.5 revealed ran-
domly multifocal, randomly scattered, variably sized hemor-
rhages up to 2 mm in diameter and the absence of normal su-
perficial vasculature. There was thickening of the amnion due
to edema present in the membranes and the prominent amniotic
blood vessels were not evident (Fig. 2 C, a–d). At E14.5 and
later, there were different degrees of lesion severity in the
CFKO embryos that ranged from large multifocal superficial
scattered hemorrhages and superficial edema to early embry-
onic death characterized by discolored embryos with a fragile
 
Table II. 
 
Genotypes of progeny from crosses between FAK
 
flox/flox
 
 and FAK
 
 
 
/
 
 
 
; Tie2Cre mice
E8.5 E9.5 E10.5 E11.5 E12.5 E13.5 E14.5 E15.5 E16.5 E17.5 Born
 
flox/
 
 
 
8 1 1 3 52 43 04 12 42 81 1 85 2
flox/
 
 
 
; Tie2Cre (CFKO) 9 11 28 23 28 23 10 6 1 1 5
flox/
 
 
 
10 10 36 25 33 42 25 28 12 7 54
flox/
 
 
 
; Tie2Cre 9 11 35 27 32 41 22 24 10 7 52
# Litter 4 6 16 13 17 24 11 13 7 3 29
Figure 3. Whole-mount staining of PECAM-1 of the embryos and yolk sacs.
(A) E10.5 embryos. There is no difference of vascular structures at this
stage between the control and CFKO embryos. (B) E13.5 embryos. Typi-
cal defects in the vascular network observed in the CFKO embryos are
shown. There is lack of the superficial vascular network in the head region
(long arrows), no clearly defined visceral outlines, and no clear definition
of the axial skeleton at the coccigeal level (corresponding part marked by
short arrow for the control embryo) when compared with the control embryo.
(C) Characteristic decrease of superficial vasculature with absence of
small vessel branch formation in the yolk sacs of CFKO embryos. 
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underdeveloped appearance (Fig. 2 C, e and f). These results
suggest probable vascular defects in late embryogenesis in the
CFKO embryos.
To test this possibility directly, we performed whole
mount staining of PECAM-1 in the CFKO and control embryos
at different embryonic stages. At E10.5, the vascular patterns
were similar between the CFKO and control littermate em-
bryos (Fig. 3 A). However, at E13.5 there was significantly
reduced vascular network in the head region of the CFKO em-
bryos when compared with control embryos (Fig. 3 B). There
were no clear outlines of internal viscera and the axial skeleton
in the CFKO embryos. In the yolk sac of E13.5 CFKO em-
bryos, there was a marked decrease in sprouting angiogenesis
and much fewer branched vessels compared with the controls
(Fig. 3 C). Together, these results strongly suggest that inacti-
vation of FAK in ECs leads to defects in vascular development
Figure 4. Vascular lesions and associated defects of CFKO embryos and placentas. (A) Histopathological sections of skin from the dorsum of control and
CFKO embryos. There is marked expansion of the dermis and subcutaneous tissue of the CFKO embryos by hemorrhage and edema. RBC, red blood
cells. (B) Histopathological section of a median plane at the level of the thoracolumbar region of control and CFKO embryos. Distinctive expansion of the
subcutaneous tissue in the CFKO embryos due to edema and engorged capillaries with perivascular hemorrhages; the brown fat (BF) pads are smaller
with pyknotic nuclei and scant eosinophilic cytoplasm. The muscle mass (MM) is reduced significantly (bracketed). Insets show RBC inside the EC-lined ves-
sels in control embryos, but both inside and outside of the capillaries in CFKO embryos. (C) Hematoxylin and eosin staining and immunohistochemical
staining with anti-vWF show the normal capillaries with RBC in the control embryos and collapsed vessels lined by defective ECs in the CFKO embryos.
Some of the ECs are pyknotic with karyorrhectic debris (red arrowheads), others are swollen and rounded (arrows), and a few have sloughed into the
lumen of the vessel. The collapsed vessels are outlined with lumina marked by asterisks. (D) Hoechst staining of control and CFKO embryos. Presence of
apoptotic ECs in the CFKO (but not control) embryos are marked by the long arrow. (E) Histopathological sections from E13.5 embryos implantation site.
Typical examples of decreased thickness of the labyrinth area in the CFKO embryos compared with the controls (top panels). The arterial canals and
branches on the CFKO labyrinth have collapsed vessel outlines and the lumina are devoid of nucleated fetal RBCs (bottom panels and graph). D, decidua;
L, labyrinth layer; T, trophoblast. 
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and angiogenesis, which are likely responsible for the hemor-
rhage, edema, and death in late embryogenesis.
 
Increased EC death and blood vessel 
collapse in the CFKO embryos
 
Consistent with the findings of gross embryonic analysis (see
Fig. 2 and Fig. 3), histological studies of the CFKO embryos at
E13.5 or later showed marked thickening and expansion of the
dermis by loosely arranged mesenchymal cells mixed with acel-
lular pale esosinophilic material, when compared with the nor-
mal thin compacted dermis and subcutaneous tissue in the con-
trol embryos (Fig. 4, A and B). The affected subcutaneous
tissue had numerous perivascular hemorrhages of variable size,
whereas the control embryos had intact blood vessels (Fig. 4, A
and B). We also observed that the lining ECs confined to the
small capillaries of the CFKO embryos had pyknotic and kary-
orrhectic changes reflecting individual cell necrosis of ECs.
Many ECs were rounded, detached, and sloughing into the lu-
men. The lumen of the affected blood vessels was collapsed
(Fig. 4 C, right panels). In contrast, the lining ECs of the control
embryos were flat and thin with elongated and intact nuclei. The
structure of the blood vessels was intact and filled with nucle-
ated red blood cells (Fig. 4 C, left panels). Staining of the subcu-
taneous sections with Hoechst revealed some apoptotic ECs in
the CFKO embryos, but not in the control embryos (Fig. 4 D).
Together, these results suggest that destruction of ECs and con-
sequent collapse of blood vessels may be responsible for the ex-
tensive defects in angiogenesis and vascular development as a
result of FAK inactivation in the ECs of CFKO embryos.
 
Defective vascularization of placenta in 
the CFKO embryos
 
A general developmental delay was evident based on the
smaller overall size of the CFKO embryos compared with lit-
termate controls. These defects and late embryonic lethality are
consistent with deficiencies of angiogenesis and vascular de-
velopment in the CFKO embryos and/or placenta. Thus, we an-
alyzed vascularization in the CFKO placenta by histology. Fig.
4 E shows that the labyrinth layer of the CFKO placenta was
markedly reduced in thickness as compared with the control lit-
termates. The arterial canals and the canal branches of the
CFKO placenta were devoid of nucleated fetal RBCs, and
some of these blood vessels appeared collapsed. As the devel-
oping embryonic hearts appear normal (unpublished data), the
lack of fetal RBCs is unlikely due to decreased perfusion from
the fetal hearts, but rather caused by the defective vasculature
in the placenta. Although it is not clear whether this placental
insufficiency was the cause for the late embryonic lethality of
CFKO embryos, these data together demonstrate a critical role
of FAK for the development and function of endothelium in
both embryos and placenta.
 
Deletion of FAK in isolated primary ECs 
results in reduced capillary formation 
and multiple cellular deficiencies in vitro
 
To further understand the mechanisms of the endothelial defects
in CFKO embryos, we isolated primary ECs from homozygous
floxed FAK mice. The isolated floxed FAK ECs were infected
by recombinant adenoviruses encoding Cre recombinase (Ad-
Cre). As shown in Fig. 5 A, Ad-Cre infection of the floxed FAK
ECs led to a dose-dependent decrease in the expression of FAK
protein concomitant with excision of exon 3 of FAK gene. As
expected, infection of the cells with a control recombinant ade-
novirus encoding lacZ (Ad-lacZ) did not affect FAK protein
expression or the flox allele of the FAK gene. These ECs are
designated as CFKO and control ECs, respectively.
The effect of FAK inactivation in the isolated ECs was
assessed by examining their ability to change morphology and
form capillaries when cultured on Matrigel, which is a process
mimicking sprouting and tube formation during angiogenesis
in vivo. Fig. 5 B shows the significantly reduced formation of
tubules of CFKO ECs compared with the control ECs. Quanti-
Figure 5. Defective tubulogenesis of the isolated FAK
 /  primary ECs.
(A) ECs isolated from homozygous floxed FAK mice (flox/flox) were in-
fected with increasing amount of recombinant adenoviruses encoding Cre
(Ad-Cre) or a control insert (Ad-lacZ), as indicated. Cell lysates were ana-
lyzed by Western blotting with anti-FAK or anti-vinculin (top two panels).
Genomic DNA was analyzed by PCR (bottom two panels). (B–D) Primary
ECs from floxed FAK mice and infected with Ad-Cre or Ad-lacZ were cul-
tured on Matrigel as described in Materials and methods. Images of repre-
sentative fields are shown in B. The length of the tubules (C) and branch
points (D) were quantified from three independent experiments and
shown as the relative ratio of the value   standard error. *, P   0.023 and
**, P   0.017 in comparison to value from Ad-lacZ–induced cells. FAK KNOCKOUT IN EC AND VASCULAR DEVELOPMENT • SHEN ET AL. 947
tation of multiple experiments indicated that both the length of
the tubules and the number of branch points were reduced in
the CFKO ECs (Fig. 5, C and D). Interestingly, consistent with
EC necrosis and apoptosis observed in the CFKO embryos
(see Fig. 4, C and D), we noted that some of CFKO ECs, but
few control ECs, appeared to be apoptotic under this condition.
Indeed, the CFKO ECs showed reduced survival in serum-free
condition when compared with the control ECs (unpublished
data). TUNEL assay was then performed to test a possible role
of FAK on EC apoptosis directly. Fig. 6 A shows that inactiva-
tion of FAK resulted in increased apoptosis of the primary
ECs. These results suggested that increased apoptosis and de-
creased survival of ECs upon FAK KO may be responsible for
the defective vascular development and associated hemorrhage
and edema, and possibly also reduced angiogenesis in the
CFKO embryos.
We also investigated the effects of FAK inactivation on
the proliferation and migration of the primary ECs to determine
the contribution of their possible changes to the in vivo vascu-
lar defects of CFKO embryos. Fig. 6 B shows a decreased cell
cycle progression of CFKO ECs upon serum stimulation in
comparison to control ECs, as measured by the BrdU incorpo-
ration as described in Materials and methods. Analysis of cell
migration using the Boyden chamber assays showed reduced
migration of CFKO ECs in response to VEGF stimulation
compared with control ECs. Surprisingly, however, little dif-
ference was observed between the CFKO and control ECs in
their migration in response to FN (Fig. 6 C). The important role
of FAK in FN-stimulated migration is well described for many
cell types, including ECs in previous studies (Parsons, 2003;
Schlaepfer and Mitra, 2004). Therefore, we further investigated
migration of CFKO ECs using the potentially more physiologi-
cally relevant wound closure assays. Fig. 6 D shows that dele-
tion of FAK reduced EC migration in response to both FN and
VEGF. As both EC migration and proliferation are critical for
angiogenesis, these data suggested that reduced proliferation
and migration of ECs upon FAK deletion could both contribute
to the defective angiogenesis in the CFKO embryos in vivo.
Differential requirement of FAK kinase 
activity in VEGF-stimulated EC migration
To gain more insights into the role of FAK in EC migration in
response to VEGF and FN as well as its potential differential
function in various cell types, we prepared recombinant adeno-
viruses encoding FAK (Ad-FAK) and its kinase-defective
mutant (Ad-KD) and examined their ability to rescue cell mi-
gration deficiency upon deletion of endogenous FAK. The iso-
lated floxed FAK ECs were infected sequentially by Ad-Cre
and Ad-FAK, Ad-KD, or a control recombinant adenovirus
Ad-GFP, as described in Materials and methods. As shown in
Fig. 7 A, infection with Ad-FAK or Ad-KD, but not Ad-GFP,
led to expression of the exogenous FAK in the CFKO ECs.
Analysis of the exogenous FAK with anti-PY397 antibody
(specific for the major FAK autophosphorylation site Y397)
showed that FAK is phosphorylated at this site, whereas the
KD mutant is not. As expected, reexpression of FAK rescued
their deficiency in VEGF- and FN-stimulated migration (Fig. 7,
B and C). Interestingly, however, reexpression of FAK KD
mutant rescued CFKO EC migration in response to FN (Fig. 7
C), but not VEGF (Fig. 7 B). We also isolated mouse embryonic
fibroblasts (MEFs) from the floxed FAK mice and examined
their migration upon deletion of FAK via Ad-Cre infection
(CFKO MEF). In contrast to results from ECs, deletion of FAK
only affected MEF migration in response to FN, but not to
VEGF (Fig. 7 D). As in the case of EC migration on FN, both
wild-type and KD mutant FAK rescued CFKO MEF migration
on FN (Fig. 7 E). Together, these results suggest that FAK may
play differential roles in migration of EC and MEF and that
FAK activity is required for VEGF-stimulated EC migration,
whereas it is dispensable for FN-stimulated migration of either
EC or MEF.
Reduced paxillin phosphorylation and 
decreased MAP kinase signaling in FAK-
deficient ECs
Multiple targets and signaling pathways have been implicated
in mediating regulation of cellular functions by FAK (Parsons,
Figure 6. Increased apoptosis, and reduced proliferation and migration
of the isolated FAK
 /  primary ECs. Primary ECs from floxed FAK mice and
infected with Ad-lacZ or Ad-Cre were measured for apoptosis using TUNEL
assay (A), proliferation by BrdU incorporation assay (B), and migration in
response to VEGF or FN by Boyden chamber assay (C) and wound closure
assay (D), as described in Materials and methods. The mean   standard
error from at least three experiments is shown. *, P   0.014 and **, P  
0.001 in comparison to value from Ad-lacZ–infected cells.JCB • VOLUME 169 • NUMBER 6 • 2005 948
2003; Schlaepfer and Mitra, 2004). The activation states of
several FAK targets were examined. As shown in Fig. 8 A,
FAK expression is abolished in the CFKO ECs compared with
the control ECs. In contrast to FAK-null cells from the total
FAK KO embryos (Sieg et al., 1998), the FAK-related tyrosine
kinase Pyk2 was not up-regulated in the absence of FAK in
ECs. Furthermore, the major FAK target paxillin showed a sig-
nificant decrease in phosphorylation at Tyr 118 in CFKO ECs
that is critical for paxillin regulation of cell spreading and mi-
gration (Petit et al., 2000). Phosphorylations of JNK (C-Jun
NH2-terminal kinase) and Erk1/2 were also decreased in the
CFKO ECs. Consistent with the absence of FAK and reduced
paxillin phosphorylation, we found a marked reduction of ty-
rosine phosphorylation staining in focal contacts with a phos-
photyrosine-specific antibody (PY20) (Fig. 8 B). Staining of
focal contacts with anti-vinculin showed an increased number
of focal contacts in CFKO ECs than control ECs, as observed
previously in the fibroblasts from total KO embryos (Ilic et al.,
1995), suggesting that reduced phosphotyrosine staining is not
due to a reduction in focal contacts in the CFKO ECs, per se.
Together, these data suggest that deficiencies in paxillin phos-
phorylation and JNK and Erk signaling may be responsible
for the cellular defects in the isolated primary CFKO ECs in
vitro and defective angiogenesis and vascular development of
CFKO embryos in vivo.
EC-specific FAK transgene expression 
cannot rescue total FAK KO embryonic 
lethality
Together with the previous studies showing early embryonic
lethality of FAK total KO embryos (Ilic et al., 1995), our re-
sults here suggested that FAK is required for both early and
late embryogenesis perhaps in different cells/tissues. To further
test this possibility, we examined whether restoration of FAK
expression in ECs would rescue the early embryonic lethal
phenotype of the total KO embryos. We have previously gener-
ated FAK transgenic mice with EC-specific expression of the
FAK transgene under the control of Tie2 promoter/enhancer
(Peng et al., 2004). These mice were crossed with FAK
 /  het-
erozygous mice to introduce Tie2-FAK transgene into the
FAK-null background, which were then intercrossed for the
generation of possibly rescued progeny with FAK
 / ; Tie2-
FAK genotype. Of the 84 pups analyzed, we did not obtain any
offspring with the rescued genotype, although the Mendelian
ratio of this genotype for the crossing is 12.5%. These results
suggest that introduction of EC-specific FAK gene could not
rescue the early embryonic lethal phenotype of the total FAK
KO embryos. They provide further support for the role of FAK
in both early embryogenesis (perhaps for mesoderm cells) and
vascular development in late embryogenesis.
Discussion
As a critical mediator of signaling by integrins and growth fac-
tor receptors, FAK has been implicated in playing an important
role in the regulation and function of ECs by a number of studies
in vitro (Romer et al., 1994; Kim et al., 2000a; Qi and Claesson-
Welsh, 2001). Furthermore, vascular defects were observed in
FAK total KO embryos and ECs from these embryos or cultured
embryoid bodies (Ilic et al., 1995, 2003). However, the early
embryonic lethality of the total KO mice precluded in vivo anal-
ysis of potential roles of FAK in angiogenesis, which is an inte-
gral part of vascular development in late embryogenesis and
adult organisms. Using a conditional KO approach that specifi-
cally inactivates FAK gene in ECs, we found that FAK expres-
sion is required for the vascular development in late embryogen-
esis. Although they developed normally, including formation
of the vascular structures in early embryogenesis, the CFKO
Figure 7. Differential requirement of FAK ki-
nase activity for VEGF-stimulated EC migration.
(A–C) Primary ECs from floxed FAK mice
were infected with Ad-Cre to delete endoge-
nous FAK followed by infection of Ad-FAK,
Ad-KD, or the control Ad-GFP as indicated.
Aliquots of lysates were analyzed by Western
blotting using anti-FAK, anti-pY397, or anti-
vinculin, as indicated (A). The infected cells
were subjected to wound closure assay in re-
sponse to VEGF (B) or FN (C), as described in
Materials and methods. The mean   stan-
dard error from at least three experiments is
shown. *, P   0.005; **, P   0.448; and
***, P   0.012 in comparison to value from
Ad-GFP–infected cells. (D and E) MEFs were
isolated from floxed FAK mice, and then in-
fected with Ad-lacZ or Ad-Cre (D) or Ad-Cre
followed by Ad-FAK, Ad-KD, or the control
Ad-GFP (E), as indicated. The infected cells
were then subjected to wound closure assays
in response to VEGF (D as indicated) or FN
(D as indicated and E). The mean   standard
error from at least three experiments is
shown. *, P   0.01 and **, P   0.17 in
comparison to value from (D) Ad-lacZ– or (E)
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embryos showed multiple defects in late embryogenesis includ-
ing reduced blood vessel network in the superficial vasculature,
hemorrhage, edema, developmental delay in the embryos, ab-
normalities of blood vessels in both yolk sac and placental laby-
rinth, and embryonic lethality. Furthermore, we showed that
EC-specific expression of a FAK transgene could not rescue the
early embryonic lethality of the total KO embryos. These studies
demonstrate that FAK is required for angiogenesis and vascular
development and integrity in late embryogenesis, and together
with the previous total KO data (Ilic et al., 1995), they suggest
that FAK plays a role in at least two different stages of embry-
onic development in multiple cell/tissue types.
The apparently normal vasculature of CFKO embryos at
E10.5 suggested that FAK is not required for vasculogenesis
during early embryonic development. This is somewhat sur-
prising given the previous observation of extensive vascular
defects in the FAK total KO mice (Ilic et al., 1995). One possi-
bility is that the FAK gene is not completely deleted at this
early stage of development. However, previous analysis sug-
gested that both the endogenous Tie2 and Tie2-Cre transgenes
were expressed as early as E7.5 in ECs and their precursor he-
mangioblasts (Schlaeger et al., 1995, 1997; Kisanuki et al.,
2001). Effective cleavage of floxed genes and associated vas-
cular defects in early embryogenesis were also shown in recent
studies using Tie2-Cre transgenic mice (Cattelino et al., 2003;
Friedrich et al., 2004). Lastly, our data also showed that FAK is
absent in ECs at or before E9.5. Therefore, this possibility is
unlikely to explain the lack of vascular defects in CFKO during
vasculogenesis, although we cannot completely exclude such a
possibility. An alternative possibility is that abnormalities in
other cells/tissues of total KO embryos (e.g., other tissues de-
rived from the defective mesoderm) could be responsible for
the deficiencies in vasculogenesis in these embryos. In contrast
to the total KO embryos, vasculogenesis proceeded normally in
the CFKO embryos described here because FAK is inactivated
only in ECs, and these other cells/tissues are not affected in
CFKO embryos. Another interesting possibility is that the de-
fects in vasculogenesis observed in the total KO embryos are
due to defects in mesoderm tissues from which ECs are de-
rived. It is possible that one or more FAK-regulated gene could
be inactivated in these tissues in the total KO embryo (but not
in the CFKO embryos described here), which could then lead
to the vasculogenesis defects, whereas inactivation of FAK it-
self in ECs would not. FAK has been shown to regulate expres-
sion of a variety of genes involved in the regulation of cell cy-
cle progression and migration (Zhao et al., 2003). Interestingly,
a recent paper showed that pleiotrophin is down-regulated in
the early FAK total KO embryos (Ilic et al., 2003), which is a
protein with multiple functions in development (Zhang and
Deuel, 1999; Souttou et al., 2001). It is clear that future studies
will be necessary to test these possibilities and identify poten-
tial key target genes and mechanisms involved in the FAK reg-
ulation of vasculogenesis in early embryonic development.
A role for FAK expression in ECs for angiogenesis and
vascular development and integrity in late embryogenesis is
suggested by our observation of multiple vascular defects in
the CFKO embryos. Consistent with previous studies of FAK
using HUVEC cells (Romer et al., 1994; Gilmore and Romer,
1996; Kim et al., 2000a; Qi and Claesson-Welsh, 2001; Ilic et
al., 2003), we found that deletion of FAK in primary ECs led
to increased apoptosis, reduced proliferation and migration,
and reduced ability to form capillaries on Matrigel. As embry-
onic angiogenesis involves both EC proliferation and migra-
tion, the above cellular defects could contribute to the reduced
angiogenesis in CFKO embryos in vivo. Interestingly, consis-
tent with inactivation of FAK, tyrosine phosphorylation of
paxillin at Tyr118 is significantly reduced in the CFKO ECs.
Paxillin is a focal adhesion protein and major substrate for the
FAK/Src complex, and has been shown to play important
roles in the regulation of cell adhesion and migration (Turner,
1998; Petit et al., 2000; Schaller, 2004). We also observed de-
creases of JNK and Erk1/2 activities in CFKO ECs, which are
consistent with previous studies showing regulation of cell cycle
progression and migration by FAK via both of these pathways
(Parsons, 2003; Schlaepfer and Mitra, 2004). Thus, reduced
paxillin phosphorylation, JNK and/or Erk signaling could
contribute to the reduced cell migration and proliferation in
the primary CFKO ECs and defective angiogenesis in the
CFKO embryos.
Figure 8. Effects of FAK deletion on downstream targets in the isolated
primary ECs. (A) Cell lysates of primary ECs from floxed FAK mice and in-
fected with Ad-lacZ or Ad-Cre were analyzed by Western blotting with
various antibodies as indicated. (B) Immunofluorescent staining of the
above ECs (see A) with anti-phosphotyrosine antibody PY20 (top panels)
or anti-vinculin (bottom panels). Focal adhesions are marked by arrows.JCB • VOLUME 169 • NUMBER 6 • 2005 950
Our analysis of FAK and its kinase-defective mutant in
their ability to rescue migration deficiency of primary ECs and
MEFs suggested a potential kinase-independent function for
FAK. We found that although FAK kinase activity is required
for VEGF-stimulated EC migration, it is dispensable for FN-
stimulated migration of either EC or MEF. The ability of KD
mutant to rescue migration of EC and MEF on FN is consis-
tent with our previous observation that it promoted migration
of CHO cells as effectively as the wild-type FAK (Cary et al.,
1996). This activity was attributed to trans-phosphorylation of
the KD mutant by endogenous FAK in CHO cells, allowing it
to function in a similar manner as wild-type and phosphory-
lated FAK. In the case of ECs and MEFs here, however, en-
dogenous FAK was deleted from these cells and the KD mu-
tant in ECs was not phosphorylated on Y397. Therefore, these
results suggest that promotion of migration of both EC and
MEF on FN by FAK is independent of its kinase activity.
They reveal potentially differential roles of FAK in mediating
cell migration on ECM such as FN and growth factors like
VEGF. Future studies will be needed to understand the poten-
tial kinase-independent function of FAK as well as the mecha-
nisms underlying a differential role of FAK in EC migration
on FN and VEGF.
Cell–cell junctions play key roles in the regulation of
ECs. Interestingly, in a recent study FAK has been suggested to
play a role in N-cadherin function in HeLa cells (Schaller,
2004; Yano et al., 2004). Therefore, FAK inactivation in the
ECs may also lead to defects in EC junctions mediated by VE-
cadherin, which may lead to hemorrhage and edema in the
CFKO embryos. Furthermore, the reduced CFKO EC survival
and increased apoptosis observed in vitro may also contribute
to a decreased vascular integrity and these phenotypes. Indeed,
signs of EC death and collapsed vessels were also observed in
the CFKO embryos in vivo. Given the multiple targets of FAK
for different cellular functions, future studies will be necessary
to further clarify the roles of various FAK downstream signal-
ing pathways in the regulation of various EC functions in vitro
and angiogenesis and vascular development in vivo. A poten-
tially powerful approach is to use various FAK mutants defec-
tive in interaction with specific targets to rescue the EC and
embryonic phenotypes of CFKO.
In addition to the various embryonic defects in late em-
bryogenesis, we also observed defects in the CFKO placenta,
which is a highly vascularized tissue and is also responsible for
sustaining the development of the embryos. We found reduced
thickness of the labyrinth layer, collapsed vessels, and lack of
fetal RBCs in the vessels. Although the placenta defects could
certainly contribute to the abnormalities in the CFKO embryos,
it is not clear at present whether potential placenta insuffi-
ciency or the embryonic vascular defects (or both) are respon-
sible for the late embryonic lethal phenotype in the majority of
CFKO embryos. We noted, however, that the EC defects in the
embryos appear to be more severe than those in the placenta
(e.g., necrotic ECs in the embryos, see Fig. 4, C and D), possi-
bly due to the intact maternal vessels that may provide nutrient
support for the adjacent fetal ECs. This suggests that placenta
insufficiency is not likely to be responsible for the defective
angiogenesis and vascular development in the embryos. It is
also interesting that EC-specific KO of integrin-linked kinase
led to placenta insufficiency and severe embryonic develop-
mental delay at E9.5 and embryo death and resorption by E11.5
and E12.5 (Friedrich et al., 2004). However, CFKO embryos
exhibited defective vascular phenotypes at a later stage and in-
deed appear normal in E10.5–E12.5. These results also sug-
gested that FAK and integrin-linked kinase, two important me-
diators of integrin signaling and function, may play differential
roles in EC development and embryogenesis.
In conclusion, our establishment and analysis of EC-spe-
cific FAK KO mice demonstrate that FAK is required for an-
giogenesis and vascular development and integrity in late em-
bryogenesis. Together with the previous studies showing a
role of FAK in early embryogenesis (Ilic et al., 1995), these
studies suggest that FAK signaling plays important roles in at
least two stages of embryonic development and perhaps in dif-
ferent cell/tissue populations. These models will allow us to
further delineate the role of specific FAK downstream path-
ways in EC functions and vascular development by rescuing
the various phenotypes with FAK mutants lacking specific in-
teractions with its targets. In addition, analysis of the small
fraction of EC-specific CFKO mice that survived to adulthood
may reveal the function of FAK in adult ECs and its potential
role in biological processes such as tumor angiogenesis in
mouse models.
Materials and methods
Construction of the targeting vector and generation of floxed FAK mice
A 422-bp EcoRI fragment of chicken FAK cDNA from pBS-FAK (Cary et
al., 1998) was used to screen a 129/SvJ BAC Mouse I hybridization li-
brary (Genome Systems, Inc.) by Southern hybridization to isolate the
genomic clones containing exon 3 of FAK. The genomic clones along with
plasmids containing loxP sites, a neomycin-resistant cassette (neo) fol-
lowed by a loxP site, and HSV-TK were then used to construct the targeting
vector (Fig. 1 A). The resulting vector contains the 5  (left) and 3  (right)
arms of 9- and 1.6-kb FAK genomic sequences, respectively, for homolo-
gous recombination.
Electroporation, selection, and blastocyst injection of E14.1 embry-
onic stem cells were essentially as described previously (Chiang et al.,
2000). For Southern blotting, a 510-bp DNA fragment located at 3  of the
right arm of the targeting vector was used (Fig. 1 A). Chimeric mice were
identified by coat color and then were bred to C57BL/6J mice. Transmis-
sion of the germ line was identified by PCR (see below) and confirmed by
Southern blotting.
EIIa-Cre transgenic mice were obtained from Jackson Laboratory
and Tie2-Cre transgenic mice have been described previously (Koni et al.,
2001). All mice used in this study were bred and maintained at Cornell
University Transgenic Animal Core Facility (Ithaca, NY) under specific
pathogen-free conditions in accordance with institutional guidelines.
Genotyping by PCR
Mice and embryos were genotyped by PCR analysis of genomic DNA.
Isolation of genomic DNA was described previously (Chiang et al.,
2000). Primers used to genotype FAK alleles were P1, 5 -GCTGATGTC-
CCAAGCTATTCC-3 ; P2, 5 -TGGCCTGCTATGGATTTCGC-3 ; and P3,
5 -AGGGCTGGTCTGCGCTGACAGG-3 , as shown in Fig. 1 A. The com-
bination of the P1 and P3 primers amplifies 1.6-kb, 1.5-kb, and 550-bp
fragments from the FAK
flox, wild-type, and FAK
  alleles, respectively. Use
of the P2 and P3 primers amplified a 370-bp fragment from either the
FAK
flox or wild-type allele, but nothing from the FAK
  allele. PCR were per-
formed for 30 cycles of 94 C (3 min), 67 C (2 min), and 72 C (4 min).
CreF (5 -CGCAGAACCTGAAGATGTTCGCGATTA-3 ) and CreR (5 -
TCTCCCACCGTCAGTACGTGAGATATC-3 ) primers were used to detect
the Cre transgene, which generate a 400-bp fragment after 35 cycles of FAK KNOCKOUT IN EC AND VASCULAR DEVELOPMENT • SHEN ET AL. 951
95 C (30 s), 60 C (30 s), and 72 C (30 s). Tie2-FAK transgene was de-
tected as described previously (Peng et al., 2004).
Western blotting
Tissue samples, embryos, and cells were homogenized and extracts were
used for Western blotting analysis as described previously (Peng et al.,
2004). Antibodies used are anti-FAK (C20; Santa Cruz Biotechnology,
Inc.), anti-vinculin (Sigma-Aldrich), anti-Pyk2 (Zheng et al., 1998), anti-
phospho-tyrosine397-FAK and anti-phospho-tyrosine118-paxillin (Upstate
Biotechnology), anti-phospho-JNK (Cell Signaling Technology), or anti-
phospho-Erk1/2 (New England Biolabs, Inc.).
Morphological and histological analysis
Timed matings were set up between male FAK
 / ; Tie2-Cre mice and fe-
male FAK
flox/flox mice. Embryos, yolk sacs, and placenta were harvested
between E8.5 and E17.5, fixed in 4% PFA in PBS at 4 C for 4–16 h, and
transferred to 70% ethanol. They were examined and photographed on a
dissecting microscope (model S6D; Leica) with a progressive 3CCD cam-
era (Sony) and Image-Pro Plus ver. 3.0.00.00 at RT. The embryos and
placenta were embedded in paraffin, sectioned (5  m), and stained with
hematoxylin and eosin, nuclear dye Hoechst 33258 (Sigma-Aldrich), or
used for immunohistochemistry. They were examined under a microscope
(model BX41; Olympus) with UplanF1  10/0.3 or UplanF1  20/0.5
objective lenses at RT, and the images were captured using a camera
(model DP70; Olympus) with DP Controller Ver. 1.2.1.108.
Immunohistochemical analysis
For immunohistochemical analysis, sections were stained after antigen
retrieval using primary antibodies against PECAM-1 (M-20, goat anti–
mouse, 1:200 dilution; Santa Cruz Biotechnology, Inc.), FAK (C-20, rab-
bit anti–mouse, 1:200; Santa Cruz Biotechnology, Inc.), or vWF (1:500;
DakoCytomation) followed by biotinylated and peroxidase-conjugated
secondary antibodies. They were then processed using the DAB Immuno-
staining assay kit (Santa Cruz Biotechnology, Inc.) according to the
instructions. The samples were usually counterstained with hematoxylin
before mounting on coverslips. They were then examined under a micro-
scope (model BX41; Olympus) with UplanF1  10/0.3 objective lens at
RT, and the images were captured using a camera (model DP70; Olym-
pus) with DP Controller ver. 1.2.1.108.
For the whole-mount staining with anti-PECAM-1 antibody, embryos
and yolk sacs were fixed in 4% PFA/PBS. After dehydration by a series of
methanol, they were treated with 1% H2O2 (diluted in MeOH and DMSO
mixed 4:1) to quench endogenous peroxidases. Samples were rehydrated
by methanol to PBS, and blocked in 4% BSA with 0.1% Triton X-100 in
PBS. They were then incubated with anti-PECAM-1 (rat monoclonal
MEC13.3, 1:50 dilution; BD Biosciences) diluted 1:10 in 4% BSA in PBST
at 4 C overnight followed by peroxidase-conjugated secondary antibod-
ies. The embryos were developed in 0.25% DAB with H2O2 in PBS. They
were examined and photographed on a dissecting microscope (model
S6D; Leica) with a progressive 3CCD camera (Sony) and Image-Pro Plus
ver. 3.0.00.00 at RT.
Culture of ECs and adenovirus infection
ECs with homozygous FAK floxed alleles were isolated from E12.5 em-
bryos using the magnetic bead (Dyanbead M-450; Dynal Corp.) purifica-
tion with rat anti–mouse PECAM-1 (BD Biosciences), as described previ-
ously (Cattelino et al., 2003; Peng et al., 2004). The endothelial nature of
the cells was confirmed by FACS and immunofluorescence microscopy with
antibodies to endothelial markers, PECAM-1 (1:100) and VE-Cadherin
(1:50). Approximately 90% purity of ECs was routinely obtained in the
preparations. Cells were cultured in high glucose DME with 20% FCS (Hy-
clone), EC growth supplement (5  g/ml; Worthington), and heparin (100
 g/ml; Sigma-Aldrich) maintenance medium (Peng et al., 2004) on gelatin-
coated tissue culture plates. MEFs with floxed FAK alleles were isolated from
E12.5 FAK
flox/flox embryos as described previously (Sage et al., 2000).
The recombinant adenoviruses encoding Cre recombinase or lacZ
control were purchased from Gene Transfer Vector Core (University of
Iowa, Iowa City, IA). For most studies, 10
8 plaque-forming units were
used for 10-cm dish. To increase efficiency, a second infection was per-
formed after 9–12 h. The recombinant adenoviruses encoding FAK (Ad-
FAK), its kinase-defective mutant (Ad-KD), or GPF control (Ad-GFP) were
generated using the Adeasy-1 system (Stratagene) according to manufac-
turer’s instruction. For the rescue experiments, cells infected with Ad-Cre
were reinfected with Ad-FAK, Ad-KD, or Ad-GFP control at 10
8 plaque-
forming units 2 d after infection of Ad-Cre to delete endogenous FAK.
No detectable cell toxicity was observed.
Tube formation assay
ECs infected with Ad-LacZ or Ad-Cre were plated on a thin layer of Matri-
gel (BD Biosciences) at 10
4 cells/well of a 96-well plate in 10% FBS DME
and allowed to form a tubular structure for 8 h to overnight. Cells were as-
sessed on their ability to form simple tube structures and their morphology.
The samples were examined on a microscope (model IX70; Olympus) with
UplanF1  10/0.3 objective lens and photographed with a progressive
3CCD camera (Sony) and Image-Pro Plus ver. 3.0.00.00 at RT. The length
and branch points were determined as described previously (Haskell et
al., 2003).
TUNEL assay
ECs infected with Ad-LacZ or Ad-Cre were assessed for apoptosis by
TUNEL assay using the In Situ Cell Death Detection Kit (Roche), according
to the manufacturer’s recommendations.
BrdU incorporation assay
2 d after infection, ECs were serum starved for 18 h to arrest the cells in
G0. BrdU incorporation assay was performed as described previously
(Zhao et al., 2003) with the following modifications. In brief, cells were re-
leased from G0 by replating the cells in 10% FBS and 150  M BrdU. After
48 h of growth, cells were fixed, treated with DNase I, and processed for
double immunofluorescent staining with anti-BrdU and anti-PECAM-1, as
described below. The percentage of BrdU ( )/ECs (PECAM-1 ) was de-
termined for  100 cells in multiple fields in each independent experiment.
Boyden chamber cell migration assay
Cell migration assays were performed using a Neuro Probe (Cabin John)
48-well chemotaxis Boyden chamber as described previously (Cary et al.,
1996) with the following modifications. 7.5   10
3 cells were added in
each upper well, and the bottom wells contained either 10 ng/ml VEGF or
10  g/ml fibronectin as chemoattractant, or DME alone as a control.
They were then incubated for 4 h in a 37 C humidified CO2 incubator.
At the end of the experiment, cells were fixed with methanol for 8 min
and stained with modified Giemsa stain (Sigma-Aldrich).
Wound closure cell migration assay
Wound closure assays were performed essentially as described previously
(Wu et al., 2004; Rodriguez et al., 2005). Infected ECs or MEFs were
plated (10
6 cells) on gelatin (for VEGF-stimulated cell migration) or FN-
coated dishes (60 mm), allowed to adhere and spread for 4 h, and then
used for assays.
Immunofluorescence staining
ECs infected with Ad-LacZ or Ad-Cre were processed for immunofluores-
cence staining as described previously (Cary et al., 1996). The primary
antibodies used were anti-phosphotyrosine (PY20; 1:100), anti-vinculin
(1:50), anti-BrdU (1:50), and anti-PECAM-1 (1:100). FITC-conjugated
goat anti–rabbit IgG (1:150) and FITC-conjugated goat anti–mouse IgG
(1:150) were used as the secondary antibodies. They were then mounted
on Slowfade (Molecular Probes, Inc.) and examined under a microscope
(model BX41; Olympus) with UplanF1  20/0.5 objective lens at RT. The
images were captured using a camera (model DP70; Olympus) with DP
Controller ver. 1.2.1.108.
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